Table 2.
Correlation of whether ophthalmologists try to switch to generics with potentially modifiable variables; positive correlations indicate that as the variable increases, so does the inclination of the provider to switch to a generic drug
Variable (question number) | Spearman correlation coefficient | Result |
---|---|---|
Patients per day (6) | −0.0408 | p = 0.70 |
Frequency of drug representative visits (10) | 0.0166 | p = 0.87 |
Knowledge of availability of generic options for commonly prescribed drugs (11) | 0.3129 | p = 0.002 |
Knowledge of price differences between generics and brand-name drugs commonly prescribed (12) | 0.2904 | p = 0.005 |
Understanding of Food and Drug Administration approval process for generics (15) | −0.0138 | p = 0.90 |
Awareness of which patients are struggling financially (16) | 0.0154 | p = 0.88 |
Feeling that patients prefer generics (17) | 0.3983 | p < 0.001 |
Inclination to prescribe a brand-name drug for more severe disease (18) | −0.3143 | p = 0.002 |
Frequency of patients asking whether a new drug being prescribed is a generic or brand name (20) | 0.0668 | p = 0.53 |
Anecdotal feeling that patient outcome is improved with brand-name drugs (21) | −0.4005 | p < 0.001 |
Desire to take a brand-name drug for own eye disease when free (22) | −0.3197 | p = 0.002 |
Desire to take a brand-name drug for own eye disease (23) | −0.4213 | p < 0.001 |